SERPINA2 and neoplasm: Collectively, such in silico analyses proposed that ARGs might correlate with several well-known oncogenes and/or Onco-pathways that contributed to the progression of Luminal and Her-2 BRCA, but the dysregulation of ARGs might inhibit the tumor-suppressing immune reactions that exaggerated the aggressive nature of Basal-like BRCA.